Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.

Lee Y, O JH, Ha S, Park C, Shin D, Moon HW, Lee JY

Open source

DOI
10.3390/diagnostics16162536
Published
2026 Aug 12
Container
Diagnostics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16162536,
  title = {Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.},
  author = {Lee Y and O JH and Ha S and Park C and Shin D and Moon HW and Lee JY},
  year = {2026},
  journal = {Diagnostics (Basel, Switzerland)},
  doi = {10.3390/diagnostics16162536},
  url = {https://doi.org/10.3390/diagnostics16162536}
}

RIS

TY  - JOUR
TI  - Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.
AU  - Lee Y
AU  - O JH
AU  - Ha S
AU  - Park C
AU  - Shin D
AU  - Moon HW
AU  - Lee JY
PY  - 2026
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16162536
UR  - https://doi.org/10.3390/diagnostics16162536
ER  - 

APA

Y, L., JH, O., S, H., C, P., D, S., HW, M., & JY, L. (2026). Florastamin Uptake on PSMA PET/CT as an Imaging Biomarker of Tumor Aggressiveness in Prostate Cancer.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16162536

Source records